In addition to cellular transcription factors, the E2 protein encoded by human papillomaviruses (HPV) modulates the viral gene expression to support the life cycle of HPV, which depends on the differentiation of the infected keratinocytes. The role of E2 as activator of viral transcription still remains unsolved. We show here that low amounts of E2 encoded by HPV16 efficiently activated the early promoter P 97 of HPV16. In addition to the long control region, this activation required high amounts of the cellular co-activator p300 and a novel binding site for CCAAT enhancer-binding protein α (C/EBPα) located downstream of the P 97 at position 480. The expression of C/EBPα was shown previously to increase during keratinocyte differentiation. By immunohistochemistry we demonstrate that the expression of p300 is induced in suprabasal epithelial cells of HPV16 positive and negative squamous epithelium. Our data suggest that high levels of p300 and C/EBPα in suprabasal layers of HPV16 positive cervical lesions allow the viral E2 protein to activate HPV16 early gene expression.
Introduction
Infection with high risk human papillomaviruses (HPV) belonging to the Alpha-papillomaviruses is a prerequisite for the development of cervical cancer. This is supported by the finding that in almost 100% of cervical cancers, HPV DNA of genital high risk types such as HPV16 and 18 can be found (Munoz, 2000) . While in benign lesions, the viral DNA is maintained as an episome, its integration into the host genome with the loss of the E2 open reading frame is thought to be a crucial step in malignant progression (Schwarz et al., 1985) . By binding to four binding sites located within the long control region (LCR), the E2 transcription factor can regulate viral transcription and replication (reviewed in Longworth and Laimins, 2004) . Reintroduction of E2 into cervical cancer cell lines such as HeLa or SiHa, which harbor integrated HPV18 and 16, respectively, results in sharp repression of E6 and E7 transcription by binding of E2 to the two promoter proximal binding sites Dowhanick et al., 1995; Goodwin and DiMaio, 2000; Nishimura et al., 2000) . The situation is different when transiently transfected reporter constructs with the long control region (LCR) including the early promoter were used. E2 was shown to weakly activate (Bouvard et al., 1994; Steger and Corbach, 1997) or weakly repress the early promoter (Soeda et al., 2006; Tan et al., 1992) . The specific effect may depend on the E2 expression level Steger and Corbach, 1997) . However with episomal, replicating HPV16 DNA, no effect of E2 on HPV16 (16E2) transcription could be observed. A close chromatin structure and methylation may impede the binding of E2 to its sites (Bechtold et al., 2003; Kim et al., 2003) . These modifications were shown to change during differentiation of the infected epithelium (Kalantari et al., 2008; Wooldridge and Laimins, 2008) .
The life cycle of HPV is linked to the differentiation program of the infected keratinocytes. The activity of the HPV16 early promoter P 97 , which slightly increases during keratinocyte differentiation, is controlled by a combination of ubiquitous transcription factors such as AP1, Oct1, TEF-1, YY1, and Sp1 binding to their sites within the LCR, with a crucial role of AP1 (reviewed in Longworth and Laimins, 2004) . There is growing evidence that the C/EBP (CCAAT/enhancer-binding protein) family of transcription factors, known to be involved in differentiation of the keratinocytes (Smith et al., 2004) , play a role in regulating transcription in the HPV life cycle as well. The C/EBP family is composed of at least six members, with C/EBPα, C/EBPβ, C/EBPδ and C/EBPζ being expressed during keratinocyte differentiation in a sequential manner. C/EBPα is found largely in suprabasal cell layers (Maytin and Habener, 1998; Bull et al., 2002) . Several C/EBP motifs were identified within the HPV16 genome. The binding of C/EBPβ to its recognition sequences within the LCR was shown to repress P 97 (Kyo et al., 1993) while two sites located within promoter 3′ sequences at pos. 580-593 and 601-614 are supposed to mediate activation of the late promoter at position 670 (P 670 ) (Kukimoto et al., 2006) . Moreover, binding of C/EBPα to sequences within the late promoter of HPV16 increased upon keratinocyte differentiation (Carson and Khan, 2006) . Fig. 1 . E2 and p300 cooperate in activation of the early promoter P 97 of HPV16. (A) Normal human primary epidermal keratinocytes (NHEK) were transfected with a luciferase reporter construct containing HPV16 sequences from position 6150 to 885 in front of the luciferase gene (16LCR-E7-Luc). As shown in the schematic overview in (B), this fragment includes in addition to P 97 , also P 670 . The four E2 binding sites are indicated. Five or 25 ng of an expression vector for 16E2 and 500 ng p300 vector were co-transfected. The basal activity of the reporter construct was set as 1 and the fold activations were calculated. The standard deviations of four independent experiments are given. (B) The reporter constructs 16LCR-E7-Luc and 16LCR-Luc, containing HPV16-specific sequences from position 7004 to 98, including P 97 , were co-transfected with 16E2 (5 and 10 ng) and p300 (500 ng) expression vectors into RTS3b cells. The activity of each reporter construct in the presence of the empty vectors was set as 1 and the fold activations obtained by E2 and/or p300 were determined. The right graph shows the relative luciferase activities (calculated by dividing the relative light units RLU by the protein concentration of the sample) of 16LCR-E7-Luc and 16LCR-Luc. (C) RNase protection assays with RNA from CaSki or RTS3b cells, transfected either with 16LCR-E7-Luc or 16LCR-E7-p97mt-Luc, containing a mutation in the TATA box of P 97 , and with expression vectors for 16E2 and p300, as indicated in the figure. As probe, radio-labeled c-RNA from position 7796 to 277 of HPV16 was used. Transcripts spliced at the splice donor at position 226 should yield a product of 129 nucleotides and unspliced transcripts a fragment of 180 nucleotides, as depicted in the overview.
The homologous cellular co-activators of transcription CBP (CREB binding protein) and p300 (here named CBP/p300) are involved in control of HPV gene expression as well. They serve as co-activators for cellular transcription factors binding to the LCR of HPV, such as AP1 or C/ EBP, and the virally encoded E2 (Lee et al., 2000; Müller et al., 2002; Peng et al., 2000) . CBP/p300 participate in a broad spectrum of biological activities including cell cycle regulation, differentiation and apoptosis. Important for co-activator activity of CBP/p300 is their acetyl-transferase (AT) activity by which they can add an acetyl group to lysine-residues of histones or other transcription factors (Kalkhoven, 2004) .
Here we set up to analyze the consequence of the interaction of 16E2 with p300 on regulation of HPV16 gene expression. We find that low amounts of 16E2 and p300 cooperated in activation of HPV16 gene expression. This activation concerned the early promoter and required high amounts of p300, the LCR as well as the binding of C/ EBPα to a novel binding site at position 480. We demonstrate that the expression of p300 is increased in the suprabasal layers of HPV16 positive cervical lesions. Our results suggest that a differentiationdependent increase in the expression of p300 and C/EBPα may enable E2 to activate HPV16 transcription.
Results
16E2 and p300 cooperate in activation of the HPV16 P 97 promoter Previously, we observed that the little activation of the late promoter of HPV8, a high risk Beta-papillomavirus infecting the skin, by low amounts of 8E2 was efficiently increased when the levels of the cellular co-activator p300 were elevated, indicating that p300 expression is a rate-limiting step in activation by E2 (Müller et al., 2002; Müller-Schiffmann et al., 2006) .
Since the interaction with p300 seems to be conserved among E2 proteins of PV (Lee et al., 2000; Müller et al., 2002; Peng et al., 2000) we tested a functional relevance of the direct interaction between 16E2 and p300 (Marcello et al., 2000 , and data not shown) on gene expression of HPV16 with an HPV16-specific reporter construct 16LCR-E7-Luc, containing in addition to the LCR also the sequences up to nt. 885 including P 670 . We used normal human epidermal keratinocytes (NHEK) in transient transfection assays. Low concentrations (5ng) of 16E2 slightly activated luciferase activity up to 2-fold, while with 25ng expression vector, 16E2 slightly repressed (0.71-fold), in correlation with previous observations (reviewed in Longworth and Laimins, 2004) . Over-expression of p300 stimulated HPV16 promoter activity 5-fold. Co-expression of 16E2 and p300 maximally yielded a 12-fold activation. With the higher amount of 16E2, the cooperation with p300 was lost. Thus, p300 and low level of 16E2 can cooperate in activation of HPV16 gene expression. Fig. 1B shows that the cooperative activation by 16E2 and p300 also takes place in RTS3b cells, an HPV-negative skin keratinocyte cell line (Purdie et al., 1993) when using 16LCR-E7-Luc. However, neither a significant activation by 16E2 or p300, respectively, nor a cooperative effect between both was observed with the reporter construct 16LCR-Luc, encoding HPV16 regulatory sequences up to position 98. Thus, significant activation of HPV16 gene expression by 16E2 and p300 requires sequences 3′ to the early promoter. Compared to 16LCR-E7-Luc, the basal activity of 16LCR-Luc was about 10-fold higher (Fig. 1B) Fig. 2. p300 expression is high in the suprabasal layers of HPV16-positive cervical sections. Immunohistochemical staining of 5 μm-thick paraffin-embedded sections of HPV16-positive CIN1-2 and CIN3 lesions and of normal cervix using either a monoclonal antibody directed against p300 or, as a negative control, IgG fraction from mouse. Sections were counter-stained by Mayers hematoxilin solution.
but the stimulation by p300 was reduced (4-fold stimulation with 16LCR-E7-Luc vs 2-fold with16LCR-Luc). Due to technical reasons, our construct 16LCR-E7-Luc started at pos. 6150, while 16LCR-Luc started at pos. 7004. Deletion of the sequences from pos. 6150 to 7003 within the 16LCR-E7-Luc-construct did not affect activation obtained by 16E2 and p300 (data not shown). (Carson and Khan, 2006; Kukimoto and Kanda, 2001; Kukimoto et al., 2006; Stünkel et al., 2000) and this work), that for hSkn1 by (Kukimoto and Kanda, 2001) , for cMyb by (Carson and Khan, 2006) and for CDP by (Stünkel et al., 2000) . The numbers beneath the drawing represent the positions of the 3′ truncated HPV16 reporter constructs used in (A). The sequence around pos. 480 is enlarged with the consensus sequence for C/EBP and CDP boxed as well as the mutations, which were introduced to eliminate binding of C/EBP factors. For the EMSA shown in the left panel, GST-C/EBPα (lanes 1, 3, and 6) and GST-C/EBPβ (lanes 2, 4, and 7) were either incubated with a radio-labeled oligonucleotide encoding the HPV16 sequence from pos. 460 to 489 (lanes 1-4) or with a mutated oligonucleotide as shown above (lanes 5-7). In lanes 3 and 4, the reactions were preincubated with an excess of non labeled wildtype oligo and analyzed on a non denaturing gel. On the right panel, the result of a CHIP-Assay, performed with extracts of SiHa cells either in the presence (lane 8) of the absence of an anti-C/EBPα antibody (lane 9) is shown. Precipitated DNA fragments were amplified by PCR using primers specific for HPV16 (pos. 356 to 532) or for actin coding sequences (C) 16LCR-E7-Luc and 16LCR-E7-480mt-Luc, with point mutations preventing the binding of C/EBP to BS480, either in the absence (16LCR-E7-480mt-Luc) or in the presence (16LCR-E7-p97mt-480mt-Luc) of mutations within the TATA box of P 97 were transiently transfected with an expression vector for C/EBPα. In the graph on the left, the relative luciferase activity (RLU) of each reporter constructs was determined. In the graph on the right, the activity of each reporter construct was set as 1 and the fold activation obtained by C/EBPα was calculated, respectively. (D) The reporter constructs 16LCR-E7-Luc and 16LCR-E7-480mt-Luc were co-transfected with expression vectors for 16E2 and p300. The fold activations by 16E2 and p300 were shown in the graph as well as the standard deviations.
In addition to P 97 , P 670 as well as other weaker promoters are present in the reporter construct 16LCR-E7-Luc (Glahder et al., 2003; Grassmann et al., 1996; Rosenstierne et al., 2003) . In order to analyze, which promoter is activated by 16E2 and p300, we performed RNase protection assays (RPA) with RNA isolated from transiently transfected RTS3b cells. As a probe to detect transcripts initiated from P 97 , we used a c-RNA from position 7769 to 277 of HPV16. The majority of the RNA expressed from P 97 is spliced from a splice donor at position 226 to alternative splice sites at position 409 or 526 (Baker and Calef, 1996) . A protected fragment of 129 nucleotides corresponds to the spliced form while the unspliced RNA yields a product of 180 nucleotides. Both fragments could be detected with RNA from CaSki cells, an HPV16-positive cervical carcinoma cell line, which we used as a positive control. No HPV16 specific signal was present when only the reporter construct was transfected. Low amounts of 16E2 induced weak signals corresponding to the spliced and unspliced P 97 -derived transcripts. The intensity of the bands was stronger after over-expression of p300, and was further enhanced, when 16E2 and p300 had been coexpressed. No signals corresponding to these transcripts were detected when using a reporter construct with a mutation of the TATA Box of P 97 (16LCR-E7-p97mt-Luc) (Fig. 1C) . When performing RPA with c-RNA probes covering the sequences around P 670 , neither 16E2 nor p300 induced a specific signal (data not shown). These results demonstrate that 16E2 and p300 activate the early promoter of HPV16.
The intracellular level of p300 is increased in the suprabasal layers of HPV16-positive CIN
The protein expression pattern of high risk HPV types in low grade CIN1 resembles that found in benign warts caused by other PV and may represent productive infection. In the suprabasal layers of the infected epithelium, E6 and E7 are expressed from P 97 to induce cell proliferation and allow genome maintenance (reviewed in Doorbar, 2006) . E2 protein was detected in paraffin-embedded sections of cervical tissue of grade CIN1 and CIN2. Its expression was confined to the superficial layers of the epithelium and specifically to the koilocytic nuclei, with little expression of the intermediate or basal layers (Maitland et al., 1998; Stevenson et al., 2000) . Our results shown in Fig. 1 suggest that efficient activation of P 97 depends on low amounts of E2, high concentrations of p300 and sequences downstream of the early promoter. In order to address whether such a regulation may be feasible during the natural life cycle of HPV16, we analyzed the expression of p300 in CIN. We performed immunohistochemical staining to detect p300 expression in paraffin-embedded sections of sixteen HPV16-positive cervical lesions of varying severity, which were used in a previous study (Weissenborn et al., 2003) and kindly provided by U. Wieland. The presence of HPV16 DNA within these lesions, which were histologically diagnosed as CINs grade 1 to 3, was determined by PCR (Weissenborn et al., 2003) . Four representative examples are shown in Fig. 2 . In general, while the nuclei of only a few of the cells within the basal layer were stained by the p300 antibody, most cells of the suprabasal layers were stained intensely and the most differentiated layers revealed no detectable or weak p300 expression. The number of layers with strongly positive cells was increased in CIN3-lesions (Fig. 2) . This expression pattern seems to be similar in normal, HPV-negative cervix, although in normal cervix, the most differentiated cells also express detectable amounts of p300. Currently, we do not know whether this difference reflects changes in expression pattern of p300 in HPV-positive cervical lesion. To verify this, a greater number of samples from normal cervix should be tested, which are currently not available. From these results and previous observations made by (Maitland et al., 1998; Stevenson et al., 2000) , it seems likely that in cells within the intermediate layers, low amounts of 16E2 and high concentrations of p300 may have the chance to meet and confer activation of P 97 .
Binding of C/EBP factors to a novel binding site at position 480 mediates the cooperative activation between 16E2 and p300
In order to map the sequence elements downstream of P 97 that mediate cooperative activation by 16E2 and p300, we constructed a set of consecutive deletion mutants starting from nt. 885. Fig. 3A reveals that the 10-fold activation obtained by 16E2 and p300 with 16LCR-E7-Luc (up to nt. 885) was reduced to 8-fold with 16LCR-641-Luc and 16LCR-523-Luc, containing HPV16 sequences up to pos. 641 and 523, respectively, although with these reporter constructs considerable variations were observed for unknown reasons. Deleting the sequences downstream of pos. 469 (16LCR-469-Luc) decreased activation by 16E2 and p300 to 5.8-fold. Another drop of activity was observed after removing the sequences downstream of nt. 394 (16LCR-394-Luc; the basis for this was not further investigated here) (Fig. 3A) .
Analyzing the 54bp located between nt. 469 and 523 by the MATInspector-program to identify putative binding sites for transcription factors revealed a consensus sequence for the family of C/EBP transcription factors from position 469-488 at the negative strand with the sequence pos.488-5′ TTATATTATGGAATCTTTG 3′ -pos.469 (see Fig. 3B , which was named BS480). The HPV16 sequence matching the consensus C/EBP motif, which is 5′ RTTGCGYAAY 3′ (with R = A or G/Y = C or T) (Kyo et al., 1993) , is underlined. The gelshift experiment shown in Fig. 3B revealed that bacterially expressed, GST fused C/EBPβ was able to specifically bind to an oligonucleotide encoding this sequence. GST-C/EBPα also induced a mobility shift of the oligonucleotide, although it was less efficient compared to C/EBPβ for unknown reasons. No complex formation was observed when a labeled oligonucleotide with mutations of the C/EBP consensus motif was used (Fig. 3B) . The binding of C/EBPα to BS 480 of HPV16 was confirmed by chromatin immunoprecipitation (ChIP). HPV16 positive SiHa cells were cross linked with formaldehyde and lysed, followed by precipitation of specific protein-DNA complexes with an antibody directed against C/EBPα. A DNA fragment covering nt. 356 to 523 of HPV16 was amplified by quantitative PCR. The agarose gel in Fig. 3B revealed that this fragment was present in the precipitate obtained with the C/EBPα antibody. Amplification of actin encoding sequences was not successful, which served as negative control. This result indicates that C/EBPα is located around nt. 480 of HPV16, integrated into the genome of SiHa cells, although we cannot certainly exclude that the precipitation of this fragment reflects the binding of C/EBPα to the previously identified binding sites for C/EBPβ at pos. 580-593 and 601-614 as well (Kukimoto et al., 2006) .
The functional relevance of this C/EBP binding site in regulation of HPV16 gene expression was analyzed by mutational analysis. The mutation destroying binding of C/EBP factors (see Fig. 3B ) slightly increased the relative luciferase activity of 16LCR-E7-Luc. Mutations eliminating the TATA box of P 97 (16LCR-E7-p97mt-Luc) led to a drop of the relative light units (RLUs) into background (RLU b 200), confirming the observation made by the RPA experiment shown in Fig. 1C that the promoter activity observed with 16LCR-E7-Luc derived solely from P 97 . The simultaneous mutation of BS480 in the context, where P 97 was eliminated (16LCR-E7-p97mt-480mt-Luc) increased RLUs above 1000 (Fig. 3C ). This implies that the binding of C/EBP factors to BS480 contributes to repression of another promoter present in the reporter construct. In over-expression assays, C/EBPβ was hardly able to activate transcription from 16LCR-E7-Luc, independently of the amount of expression vector transfected (data not shown). C/EBPβ was suggested to repress the early promoter of HPV16 and to activate the late promoter (Kukimoto et al., 2006) . Our net result may reflect these antagonizing activities. The over-expression of C/EBPα induced a 7.2 fold activation with 16LCR-E7-Luc. This activation was reduced to 4.8 fold due to the mutation of the new binding site at pos. 480 (Fig. 3C) . Presumably, this residual activation is mediated by binding of C/EBPα to the series of binding sites for C/EBP, present within the LCR and/or the region downstream of the early promoter (Kukimoto et al., 2006; Kyo et al.,1993) . The mutation of the TATA box of the P 97 eliminated any effect of over-expressed C/EBPα. However, the co-expression of C/ EBPα with 16LCR-E7-Luc-p97mt-BS480mt-Luc increased RLUs up to 2000 (Fig. 3C) . These results confirm that the binding of C/EBPα to BS480 contributes to the activation of P 97 , and to the repression of another not yet identified promoter.
C/EBPα uses p300 as co-activator (Mink et al., 1997; Schwartz et al., 2003) . Moreover, p300 was suggested to mediate cooperation between transactivators interacting with different domains of p300 (Mink et al., 1997 ). Thus we tested whether C/EBPα bound to its site at pos. 480 is involved in the cooperation between E2 and p300. Transient transfections revealed that the mutation of BS480 in the context of 16LCR-E7-Luc reduced activation by E2 and p300 from 7 fold to 3.5 fold, while single activations obtained by E2 and p300 on its own were hardly affected by the mutation (Fig. 3D) , indicating that binding of C/EBP factors to this site within HPV16 supports cooperation between E2 and p300.
Discussion
Although the composition of the regulatory regions and the regulation of gene expression between Beta-papillomaviruses and Alpha-papillomaviruses are completely different, some aspects are conserved, for instance the interaction between the viral E2 protein and p300. Previously we could show that the E2 protein of high risk cutaneous HPV8 efficiently cooperates with p300 in activation of the HPV8 late promoter (Müller et al., 2002) . Our results presented here reveal that the situation is fundamentally different in HPV16. Although E2 and p300 cooperate in activation of HPV16 gene expression as well, here the early promoter is concerned. The specific promoter targeting of E2 and p300 in HPV8 and HPV16 obviously correlates with the different availability of p300 in the tissues infected by these viruses. While we found previously that p300 is highly expressed in the most differentiated layers in normal skin (Müller et al., 2002) , immunohistochemistry shown here revealed that in mucosa of cervical dysplasias the levels of p300 are elevated in the suprabasal layers. The zone of cells expressing high amounts of p300 seems to increase during progression from CIN1 to CIN3. In low grade lesions, which contain episomal HPV16 DNA, high amounts of p300 in the suprabasal layers may allow the viral E2 protein to activate P 97 . In high grade CINs, which usually do not express E2, increased p300 co-activator level may have other functions, for instance to support cellular proliferation. In line with this model is our observation that cervical cancer cell lines such as CaSki and SiHa express higher levels of p300 compared to NHEK and RTS3b cells (data not shown). In correlation, the effect of over-expression of p300 in cervical cancer cell lines is reduced (data not shown). Thus, RTS3B and NHEK, the cells we used in this study, may reflect the situation in the basal cell layers regarding p300 expression and allow us to study the effect of increasing p300 concentrations. This set up seems to be valid, since we can demonstrate that p300 is markedly induced in suprabasal epithelial cells in both virus positive and negative squamous epithelium.
Activation by 16E2 and p300 depends on the binding of E2 to its sites (U.K. and G.S., data not shown) and on the sequences downstream of P 97 . It is becoming more and more evident that the P 97 downstream segment of HPV16 not only plays a role in regulation of P 670 , but also in modulating P 97 activity. In our hands, these sequences conferred an about 8-fold repression of P 97 . Previously, an inhibitory effect was suggested to rely on the binding of CDP/cut (CCAAT-displacement protein/cut homeodomain) to five binding sites (Stünkel et al., 2000) . CDP/cut associates with histone-deacetylase HDAC1 and thus directs the deacetylation of histone tails, which results in a more closed chromatin structure and impedes the access of transcription factors to the DNA (reviewed in Bernard, 2000; Nepveu, 2001) . In vivo, CDP/cut is expressed at high levels in undifferentiated keratinocytes and expression decreases upon differentiation (Ai et al., 1999) . Our results support the following model: in the suprabasal layers p300 might contribute to relieve repression by CDP/cut via the histone AT-activity of p300. In line with this, the acetylation state of histone H3 and H4 located around both promoter regions was shown to increase during keratinocyte differentiation in the case of HPV31 (Wooldridge and Laimins, 2008) . Moreover, in response to differentiation, methylation of episomal HPV16 DNA was lost (Kalantari et al., 2008) . These modifications may confer access of E2, expressed in some of the superficial cells (Maitland et al., 1998; Stevenson et al., 2000) to its sites within the episomal HPV16 genome and allow it to activate. Another prerequisite for cooperation with p300 is the binding of C/EBPα, expressed in suprabasal skin layers as well (Maytin and Habener, 1998) to the novel binding site at pos. 480. It seems possible that C/EBPα, directly interacting with p300 as well (Schwartz et al., 2003) assists E2-mediated recruitment of p300 to the P 97 region. On the other hand, it has been shown that C/EBPα (and also β) triggers phosphorylation of the C-terminal part of p300, resulting in increased stability and enhanced co-activator function (Schwartz et al., 2003) . It is conceivable that this C/EBP-induced modification of p300 is a prerequisite for E2 to increase transcription. Moreover, we have observed previously that E2 directly interacts with C/EBPα (Hadaschik et al., 2003) . Via this interaction E2 may be recruited to the promoter downstream segment of HPV16, which may be a prerequisite for cooperation with p300.
In addition to its contribution to activation of P 97 , the binding of C/ EBPα to the site at pos. 480 seems to repress another promoter. A CDP/ Cut motif at the coding strand overlaps with the newly identified C/EBP BS (Stünkel et al., 2000) . CDP/Cut is known to bind to AT-rich sequences normally including the sequence 5′-TAAT-3′. Our mutation destroying binding of C/EBPα leaves the CDP/Cut binding site intact (see Fig. 3B ). Thus, increased promoter activities as consequence of the mutation of the BS480 should be due to loss of binding of C/EBPα and not to altered binding of CDP/Cut. Repression of transcription by C/EBP factors may occur via dimerization of the full length protein with an N-terminally truncated version, p30, lacking the activation domain. Moreover, by recruiting the co-repressor CA150, C/EBPα may be able to selectively repress certain promoters (McFie et al., 2006) . Which promoter in HPV16 is repressed by C/EBPα? The C/EBP binding site 480 overlaps with the 5′ end of transcripts (Grassmann et al., 1996) . Thus, bound C/ EBPα might interfere with the assembly of the preinitiation complex at the corresponding promoter. However, these transcripts are upregulated during differentiation (Grassmann et al., 1996) . Upon keratinocyte differentiation increased binding of C/EBPα to the late promoter regions of HPV16 and HPV31 has been described (Carson and Khan, 2006) , making it unlikely that the promoter directing the transcripts initiating at pos. 480 or P 670 are negatively controlled by C/EBPα. The P 542 was suggested to be down regulated in differentiated epithelial cells (Glahder et al., 2003; Rosenstierne et al., 2003) . C/EBP may be implicated in the control of this promoter.
Taken together our results suggest that the differentiationdependent increase of the concentration of the cellular factors p300 and C/EBPα may enable 16E2 to activate HPV16 gene expression in the suprabasal layers of in the infected epithelium.
Materials and methods

Plasmids constructs
The expression vector for p300 was described in (Eckner et al., 1994) , that for 16E2 and the reporter construct 16LCR-Luc in (Verres et al., 1999) . The reporter construct 16LCR-E7-Luc was obtained by cloning a BamH1-Kpn1 fragment (from nt 6150 to 885) into the vector pALuc (Dong et al., 1994) . The deletion or point mutations were introduced by cloning appropriate PCR products or by site directed in vitro mutagenesis. The pcDNA3.1 based expression for C/EBPα, vectors for GST-C/EBPα and GST-C/EBPβ were described in (Hadaschik et al., 2003) . To obtain a probe for RPA, a HPV16 fragment from nucleotide 7749-277 was cloned into the vector pGEM4Z (Promega).
Cell culture and transient transfections
The skin keratinocyte cell line RTS3b (Purdie et al., 1993) was cultivated in E-medium. Primary normal human epidermal keratinocytes (NHEK) were purchased from Cambrex and cultivated in KGM2 medium. Transient transfections of RTS3b cells and NHEK, using the FuGene reagent (Roche Diagnostics), and the assaying of the luciferase activity were described previously (Müller et al., 2002; Müller-Schiffmann et al., 2006) .
Protein expression, RNase protection assays and immunohistochemical staining
Protein expression and RNase protection assays were performed as described previously (Müller-Schiffmann et al., 2006) . Paraffin embedded sections of HPV16-positive cervical specimens, used in the study from (Weissenborn et al., 2003) were stained with an antibody directed against p300 (Calbiochem) as described in (Müller et al., 2002) .
CHIP-Assay
The CHIP-Assay was performed according to the protocol of the Chromatin-Immunoprecipitation kit from Upstate. Briefly, cells were treated with formaldehyde prior harvesting and sonicated to share the chromatin solution to 300-500 bp DNA length. An antibody against C/ EBPα (14AA, Santa Cruz) was added to an aliquot of precleared lysate and incubated over night. Protein G-sepharose beads were added and the mixture was incubated for 2 h. After reversing the cross links, DNA was isolated and used for PCR reaction with the fast start DNA master SybrI green kit and a light cycler (Roche diagnostics). Finally, PCRs were repeated with 26 cycles and fragments were loaded to an agarose gel.
